AstraZeneca's diabetes drug gets FDA nod to treat heart failure

11:24pm PDT - May 5th, 2020    astrazeneca - Reuters

The U.S. Food and Drug Administration approved AstraZeneca Plc's diabetes drug to reduce the risk of cardiovascular death and hospitalisation for heart failure in certain patients, the drugmaker said on Wednesday.